SANA Logo

Sana Biotechnology, Inc. (SANA) 

NASDAQ
Market Cap
$368.39M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
34 of 960
Rank in Industry
28 of 550

Largest Insider Buys in Sector

SANA Stock Price History Chart

SANA Stock Performance

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the …

Insider Activity of Sana Biotechnology, Inc.

Over the last 12 months, insiders at Sana Biotechnology, Inc. have bought $18M and sold $1.43M worth of Sana Biotechnology, Inc. stock.

On average, over the past 5 years, insiders at Sana Biotechnology, Inc. have bought $6.23M and sold $2.85M worth of stock each year.

Highest buying activity among insiders over the last 12 months: NELSEN ROBERT () — $42M. CRANDELL KEITH (10 percent owner) — $30M. ARCH Venture Fund X, L.P. (10 percent owner) — $6M.

The last purchase of 1,090,909 shares for transaction amount of $6M was made by NELSEN ROBERT () on 2024‑02‑08.

List of Insider Buy and Sell Transactions, Sana Biotechnology, Inc.

2024-09-25Saledirector
150,000
0.0641%
$3.89$583,170+9.83%
2024-09-24Saledirector
150,000
0.0673%
$4.08$612,570+4.56%
2024-03-08Saledirector
25,000
0.0113%
$9.45$236,300-38.99%
2024-02-08Purchase
1.09M
0.5382%
$5.50$6M-0.81%
2024-02-08Purchase10 percent owner
1.09M
0.5382%
$5.50$6M-0.81%
2024-02-08Purchase10 percent owner
1.09M
0.5382%
$5.50$6M-0.81%
2023-12-15SaleEVP, Chief Business Officer
75,000
0.0378%
$4.00$300,098+46.07%
2023-06-07Sale10 percent owner
200,000
0.1051%
$6.24$1.25M-6.12%
2023-06-06Sale10 percent owner
203,758
0.106%
$6.31$1.28M-8.04%
2023-05-26Sale10 percent owner
82,000
0.0425%
$6.23$510,573-7.64%
2023-05-25Sale10 percent owner
115,372
0.0614%
$6.35$732,866-6.89%
2023-05-24Sale10 percent owner
347,870
0.1843%
$6.57$2.28M-10.19%
2022-03-21Purchase
28,000
0.016%
$7.30$204,400-19.10%
2022-02-18SaleEVP & General Counsel
333
0.0002%
$6.28$2,091-5.54%
2021-09-16SaleEVP, Head of Development & CMO
1,627
0.0009%
$26.00$42,302-69.16%
2021-09-15SaleEVP, Head of Development & CMO
58,373
0.0323%
$26.07$1.52M-69.32%
2021-09-10SaleEVP, Chief Business Officer
1,477
0.0008%
$25.00$36,925-67.78%
2021-09-09SaleEVP, Chief Business Officer
64,671
0.0361%
$25.01$1.62M-67.46%
2021-09-03SaleEVP, Chief Business Officer
700
0.0004%
$25.00$17,500-67.18%
2021-09-02SaleEVP, Chief Business Officer
7,958
0.0045%
$25.00$198,968-66.80%

Insider Historical Profitability

<0.0001%
CRANDELL KEITH10 percent owner
12446022
5.5745%
$1.6510
NELSEN ROBERT
12446022
5.5745%
$1.6510
ARCH Venture Fund X, L.P.10 percent owner
12446022
5.5745%
$1.6510
Yang Patrick Ydirector
149250
0.0668%
$1.6511<0.0001%
Bilenker Joshua H.director
20000
0.009%
$1.6510

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Flagship Pioneering$250.02M11.2925MNew+$250.02M16.4
Fidelity Investments$220.43M9.9522.04MNew+$220.43M0.02
The Vanguard Group$121.55M5.4912.16M+24.07%+$23.58M<0.01
Baillie Gifford Co$106.56M4.8110.66MNew+$106.56M0.08
Canada Pension Plan Investment Board$101.75M4.5910.18M0%+$00.1
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.